22 results on '"J. Hostens"'
Search Results
2. Poster Session: Right ventricular systolic function
- Author
-
M. Altman, C. Bergerot, H. Thibault, A. Aussoleil, E. Skuldadt Davidsen, M. Barthelet, G. A. Derumeaux, J. Grapsa, I. Zimbarra Cabrita, J. Afilalo, S. Paschou, D. Dawson, G. Durighel, D. O'regan, L. Howard, J. Gibbs, P. Nihoyannopoulos, M. Morenate Navio, M. Mesa Rubio, M. D. Ortega, M. Ruiz Ortiz, F. Castillo Bernal, C. L. Del Pino, F. Toledano, M. P. Alvarez-Ossorio, S. Ojeda Pineda, J. S. D. Lezo Cruz-Conde, R. Jasaityte, P. Claus, A. Teske, L. Herbots, B. Verheyden, F. Rademakers, J. D'hooge, C. G. Tocchetti, C. Coppola, D. Rea, C. Quintavalle, L. Guarino, N. Castaldo, C. De Lorenzo, G. Condorelli, C. Arra, N. Maurea, D. Voilliot, O. Huttin, Y. Camara, W. Djaballah, S. Carillo, P. Zinzius, J. Sellal, M. Angioi, Y. Juilliere, C. Selton-Suty, P. Dobrowolski, A. Klisiewicz, E. Florczak, A. Prejbisz, E. Szwench, J. Rybicka, A. Januszewicz, P. Hoffman, A. Jurado Roman, S. De Dios Perez, J. M. M. De Nicolas, B. Diaz Anton, B. Rubio Alonso, R. Martin Asenjo, S. Mayordomo Gomez, L. Villagraz Tecedor, L. Blazquez, R. T. De Meneses, A. Bernard, A. I. Hernandez, A. Reynaud, C. Lerclercq, J. Daubert, E. Donal, R. Arjan Singh, S. Sivarani, S. Lim, W. Azman, M. Almeida, N. Cardim, V. Fonseca, V. Carmelo, S. Santos, T. Santos, J. Toste, W. Kosmala, A. Orda, B. Karolko, A. Mysiak, M. Przewlocka-Kosmala, K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, E. Avramidou, D. Vassilopoulou, V. Voudris, H. Hayrapetyan, K. Adamyan, J. Montero Cabezas, C. Granda Nistal, B. Garcia Aranda, V. Sanchez Sanchez, A. Sestito, P. Lamendola, A. Di Franco, C. Lauria, G. Lanza, M. Kukucka, A. Unbehaun, S. Buz, A. Mladenow, H. Kuppe, M. Pasic, H. Habazettl, D. Gemma, N. Montoro Lopez, M. G. R. De Celix, T. Lopez Fernandez, F. De Torres Alba, D. I. Del Valle, U. Ramirez, J. Mesa, M. Moreno Yanguela, J. Lopez Sendon, G. W. Eveborn, H. Schirmer, P. Lunde, G. Heggelund, K. Rasmussen, Z. Wang, B. Lasota, K. Mizia-Stec, M. Mizia, A. Chmiel, T. Adamczyk, J. Chudek, Z. Gasior, A. Venkatesh, J. Johnson, A. Sahlen, L. Brodin, R. Winter, K. Shahgaldi, A. Manouras, S. Valbuena, A. Iniesta, T. Lopez, F. De Torres, P. Salinas, S. Garcia, M. Moreno, J. Lopez-Sendon, I. Lebid, T. Kobets, T. Kuzmenko, S. Katsanos, K. Yiu, M. Clavel, N. Nina Ajmone, F. Van Der Kley, J. Rodes Cabau, M. Schalij, J. Bax, P. Pibarot, V. Delgado, L. Fusini, G. Tamborini, M. Muratori, P. Gripari, N. Marsan, C. Cefalu', S. Ewe, F. Maffessanti, M. Pepi, N. Hasselberg, K. Haugaa, H. Petri, K. Berge, T. Leren, H. Bundgaard, T. Edvardsen, R. Ancona, S. Comenale Pinto, P. Caso, M. Coppola, O. Rapisarda, C. Cavallaro, F. Vecchione, A. D'onofrio, R. Calabro', R. Rimbas, S. Mihaila, O. Enescu, N. Patrascu, R. Dragoi, M. Rimbas, C. Pop, D. Vinereanu, S. Gustafsson, S. Morner, C. Gronlund, O. Suhr, P. Lindqvist, G. Di Bella, C. Zito, F. Minutoli, A. Madaffari, M. Cusma Piccione, A. Mazzeo, R. Massimo, M. Pasquale, G. Vita, S. Carerj, I. Rangel, A. Goncalves, C. Sousa, A. Correia, E. Martins, J. Silva-Cardoso, F. Macedo, M. Maciel, B. Pfeiffer, A. Rigopoulos, H. Seggewiss, M. Alvarez Fuente, T. Sainz Costa, C. Medrano, M. Navarro, D. Blazquez Gamero, J. Ramos, M. Mellado, M. De Jose, M. Munoz, E. Maroto, L. Gargani, P. Gosciniak, L. Pratali, G. Agoston, C. Bruni, S. Guiducci, M. Matucci Cerinic, A. Varga, R. Sicari, E. Picano, C. Zhao, M. Mei, C. Yeung, C. Siu, H. Tse, M. Florescu, L. Magda, R. Mincu, I. Daha, C. M. Stanescu, L. Chirila, C. Baicus, A. Vlase, G. Dan, M. Montoro Lopez, R. Florez Gomez, A. Alonso Ladreda, C. Itziar Soto, J. Rios Blanco, G. Guzman Martinez, B. Lichodziejewska, K. Kurnicka, S. Goliszek, M. Kostrubiec, O. Dzikowska-Diduch, M. Ciurzynski, A. Labyk, M. Krupa, P. Palczewski, P. Pruszczyk, C. C. De Sousa, A. Vigario, T. Pinho, J. Silva Cardoso, S.-J. Park, J.-E. Song, Y.-J. Lee, M.-R. Ha, S.-A. Chang, J.-O. Choi, S.-C. Lee, S. Park, J. Oh, A. Van De Bruaene, P. De Meester, R. Buys, L. Vanhees, M. Delcroix, J. Voigt, W. Budts, A. Blundo, S. Buccheri, I. P. Monte, S. Leggio, C. Tamburino, M. Sotaquira, R. Lang, E. Caiani, M. Floria, L. De Roy, O. Xhaet, D. Blommaert, J. Jamart, M. Gerard, O. Deceuninck, B. Marchandise, S. Seldrum, E. Schroeder, B. Unsworth, S. Sohaib, K. Kulwant-Kaur, L. Malcolme-Lawes, P. Kanagaratnam, I. Malik, B. Ren, H. Mulder, A. Haak, M. Van Stralen, T. Szili-Torok, J. Pluim, M. Geleijnse, J. Bosch, R. Baglini, A. Amaducci, G. D'ancona, S. Van Den Oord, Z. Akkus, G. Ten Kate, G. Renaud, E. Sijbrands, N. De Jong, A. Van Der Lugt, A. Van Der Steen, A. Schinkel, A. Bjallmark, M. Larsson, D. Grishenkov, L.-A. Brodin, T. Brismar, G. Paradossi, K. A. Sveen, T. Nerdrum, K. Hanssen, K. Dahl-Jorgensen, K. Steine, S. Cimino, G. Pedrizzetti, G. Tonti, E. Canali, V. Petronilli, F. Cicogna, L. Arcari, L. De Luca, C. Iacoboni, L. Agati, S. S. Abdel Moneim, S. Eifert Rain, M. Bernier, G. Bhat, M. Hagen, D. Bott-Kitslaar, R. Castello, S. Wilansky, P. Pellikka, S. Mulvagh, I. Delithanasis, J. Celutkiene, C. Kenny, M. Monaghan, W. Park, G. Hong, J. Son, S. Lee, U. Kim, J. Park, D. Shin, Y. Kim, K. Toutouzas, M. Drakopoulou, C. Aggeli, I. Felekos, C. Nikolaou, A. Synetos, K. Stathogiannis, E. Tsiamis, E. Siores, C. Stefanadis, B. Plicht, P. Kahlert, T. Grave, T. Buck, T. Konorza, M. Gursoy, T. Gokdeniz, M. Astarcioglu, Z. Bayram, B. Cakal, S. Karakoyun, M. Kalcik, R. Acar, G. Kahveci, M. Ozkan, W. Tsang, L. Weinert, S. Yurdakul, B. Avci, S. Sahin, B. Dilekci, S. Aytekin, F. Arenga, S. Hascoet, R. Martin, Y. Dulac, M. Peyre, C. Benzouid, K. Hadeed, P. Acar, D. Zakarkaite, V. Skorniakov, V. Zvironaite, V. Grabauskiene, J. Burca, L. Ciparyte, A. Laucevicius, G. Di Salvo, A. Rea, A. D'aiello, F. Del Gaizo, V. Pergola, A. D'andrea, G. Pacileo, R. Calabro, M. Russo, C. Dedobbeleer, A. Hadefi, R. Naeije, P. Unger, C. Mornos, D. Cozma, A. Ionac, A. Mornos, M. Valcovici, S. Pescariu, L. Petrescu, K. Hu, D. Liu, M. Niemann, S. Herrmann, M. Cikes, S. Stoerk, S. Knop, G. Ertl, B. Bijnens, F. Weidemann, M. De Knegt, T. Biering-Sorensen, P. Sogaard, J. Sivertsen, J. Jensen, R. Mogelvang, W. Lam, M. Tang, K. Chan, Y. Yang, F. Fang, J. Sun, C. Yu, Y. Lam, V. Panoulas, S. Sulemane, A. Bratsas, K. Konstantinou, M. Francone, T. Schau, M. Seifert, D. Ridjab, M. Schoep, M. Gottwald, M. Neuss, J. Meyhoefer, M. Zaenker, C. Butter, A. Tarr, S. Stoebe, D. Pfeiffer, A. Hagendorff, E. Maret, B.-M. Ahlander, P.-G. Bjorklund, J. Engvall, G. Staskiewicz, E. Czekajska-Chehab, P. Adamczyk, E. Siek, P. Przybylski, R. Maciejewski, A. Drop, C. Jimenez Rubio, G. Isasti Aizpurua, J. Miralles Ibarra, M. Al-Mallah, T. Somg, S. Alam, J. Chattahi, B. Zweig, K. Dhanalakota, S. Boedeker, K. Ananthasubramaniam, C. Park, K. March, S. Jones, J. Mayet, T. Tillin, N. Chaturvedi, A. Hughes, E. Hamodraka, E. Kallistratos, A. Karamanou, T. Tsoukas, D. Mavropoulos, N. Kouremenos, I. Zaharopoulou, N. Nikolaidis, D. Kremastinos, A. Manolis, M. Loboz-Rudnicka, J. Jaroch, Z. Bociaga, E. Kruszynska, B. Ciecierzynska, M. Dziuba, K. Dudek, I. Uchmanowicz, K. Loboz-Grudzien, D. Silva, A. Magalhaes, C. Jorge, N. Cortez-Dias, P. Carrilho-Ferreira, J. Silva Marques, I. Portela, C. Pascoa, A. Nunes Diogo, D. Brito, B. Roosens, G. Bala, S. Droogmans, J. Hostens, J. Somja, E. Delvenne, J. Schiettecatte, T. Lahoutte, G. Van Camp, and B. Cosyns
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Cardiology ,Radiology, Nuclear Medicine and imaging ,General Medicine ,Session (computer science) ,Systolic function ,Cardiology and Cardiovascular Medicine ,business - Published
- 2012
- Full Text
- View/download PDF
3. Poster Session 1: Thursday 8 December 2011, 08:30-12:30 * Location: Poster Area
- Author
-
S. Vijayan, M. Khanji, A. Ionescu, C. Podoleanu, A. Frigy, A. Ugri, A. Varga, D. Podoleanu, A. Incze, E. Carasca, D. Dobreanu, O. Mjolstad, H. Dalen, T. Graven, J. Kleinau, B. Hagen, H. Fu, T. Liu, J. Li, C. Liu, C. Zhou, G. Li, R. Bordese, M. Capriolo, D. Brero, I. Salvetti, M. Cannillo, M. Antolini, W. Grosso Marra, S. Frea, M. Morello, F. Gaita, F. Maffessanti, E. Caiani, D. Muraru, F. Tuveri, L. Dal Bianco, L. Badano, A. Majid, A. Soesanto, B. Ario Suryo Kuncoro, R. Sukmawan, M. H. Ganesja, T. Benedek, M. Chitu, J. Beata, Z. Suciu, I. Kovacs, O. Bucur, I. Benedek, A. Hrynkiewicz-Szymanska, F. Szymanski, G. Karpinski, K. Filipiak, Z. Radunovic, L. Lande Wekre, K. Steine, O. Bech-Hanssen, B. Rundqvist, F. Lindgren, N. Selimovic, J. Jedrzychowska-Baraniak, R. Jozwa, B. Larysz, J. Kasprzak, T. Ripp, V. Mordovin, E. Ripp, A. Ciobanu, R. Dulgheru, R. Dragoi, S. Magda, M. Florescu, S. Mihaila, R. Rimbas, M. Cinteza, D. Vinereanu, C. Benavides-Vallve, B. Pelacho, O. Iglesias, S. Castano, A. Munoz-Barrutia, F. Prosper, C. Ortiz De Solorzano, A. Manouras, A. Sahlen, R. Winter, P. Vardas, L. Brodin, S. I. Sarvari, K. H. Haugaa, W. Zahid, B. Bendz, L. Aaberge, T. Edvardsen, G. Di Bella, S. Pedri, R. Donato, A. Madaffari, C. Zito, D. Stapf, M. Schreckenberg, S. Carerj, H. Yoshikawa, M. Suzuki, Y. Kusunose, G. Hashimoto, T. Otsuka, M. Nakamura, K. Sugi, J. Grapsa, D. Dawson, W. Gin-Sing, L. Howard, J. Gibbs, P. Nihoyannopoulos, B. Smith, T. Coulter, A. Rendon, W. Gorissen, A. Shiran, I. Asmer, S. Adawi, M. Ganaeem, J. Shehadeh, M. Cameli, M. Lisi, F. Righini, M. Maccherini, G. Sani, M. Galderisi, S. Mondillo, D. Kalimanovska-Ostric, T. Nastasovic, I. Jovanovic, B. Milakovic, M. Dostanic, M. Stosic, I. Sasic, K. Sveen, T. Nerdrum, K. Hanssen, K. Dahl-Jorgensen, E. Holte, J. Vegsundvaag, T. Hole, K. Hegbom, R. Wiseth, I. Ikonomidis, J. Lekakis, V. Tritakis, I. Papadakis, N. Kadoglou, S. Tzortzis, P. Trivilou, C. Koukoulis, I. Paraskevaidis, M. Anastasiou-Nana, M. K. Smedsrud, S. Sarvari, O. Gjesdal, M. Beraldo, E. Solda', U. Cucchini, D. Peluso, M. Tuveri, A. Al Mamary, S. Iliceto, H. Dores, J. Abecasis, M. Carvalho, M. Santos, M. Andrade, R. Ribeiras, C. Reis, E. Horta, R. Gouveia, M. Mendes, D. Zaliaduonyte-Peksiene, V. Mizariene, G. Cesnaite, E. Tamuleviciute, R. Jurkevicius, J. Vaskelyte, R. Zaliunas, K. Smarz, B. Zaborska, T. Jaxa-Chamiec, P. Maciejewski, A. Budaj, D. Trifunovic, D. Sobic-Saranovic, S. Stankovic, M. Ostojic, B. Vujisic-Tesic, M. Petrovic, I. Nedeljkovic, M. Banovic, M. Tesic, I. Petrovic, I. Peovska, E. Srbinovska, J. Maksimovic, V. Andova, F. Arnaudova, E. Hristova, M. Otljanska, M. Vavlukis, S. Jovanova, G. Tamborini, L. Fusini, P. Gripari, M. Muratori, G. Pontone, D. Andreini, E. Bertella, S. Ghulam Ali, A. Bartorelli, M. Pepi, M. Cusma-Piccione, J. Salvia, F. Antonini-Canterin, S. Lentini, D. Donato, M. Miceli, G. Oreto, R. Sachner, R. Rubinshtein, M. Shnapp, T. Gaspar, A. Marchese, W. Deste, A. Sanfilippo, P. Aruta, M. Patane, G. Millan, G. Ussia, C. Tamburino, V. Kujacic, S. Obradovic, Z. Crkvenac, A. Bernard, M. Piquemal, G. Muller, P. Arbeille, B. Charbonnier, C. Broyd, J. Davies, G. Mikhail, J. Mayet, D. Francis, M. Rosca, J. Magne, C. Szymanski, B. Popescu, C. Ginghina, L. Pierard, P. Lancellotti, A. Gonzalez-Mansilla, J. Solis, R. Angulo, E. Perez-David, G. Madrid, J. Garcia-Robles, R. Yotti, R. Prieto, J. Bermejo, F. Fernandez-Aviles, Y. Ishikawa, T. Ishida, T. Osaki, M. Matsuyama, H. Yamashita, S. Ozaki, M. Stevanella, E. Votta, F. Veronesi, F. Alamanni, A. Redaelli, S. D. Park, J. Lee, S. Shin, S. Woo, D. Kim, K. Park, J. Kwan, W. Tsang, S. Chandra, L. Weinert, E. Gayat, M. Djelassi, T. Balbach, V. Mor-Avi, R. Lang, P. De Meester, A. Van De Bruaene, M. Delcroix, W. Budts, L. Abid, Z. Frikha, K. Makni, H. Rekik, A. Znazen, H. Mourad, S. Kammoun, L. Sargento, M. Satendra, C. Sousa, S. Lopes, S. Longo, N. Lousada, R. Palma Reis, D. Fouad, R. Shams Eldeen, C. Beladan, A. Calin, F. Voinea, R. Enache, R. Jurcut, I. Coman, M. Ghionea, A. Djordjevic-Dikic, O. Petrovic, M. Boricic, V. Giga, L. Pisciella, C. Lanzillo, M. Minati, S. Caselli, M. Di Roma, S. Fratini, S. Romano, L. Calo', E. Lioy, M. Penco, G. Finocchiaro, B. Pinamonti, M. Merlo, G. Barbati, G. Sinagra, A. Dilenarda, S. Comenale Pinto, R. Ancona, P. Caso, C. Cavallaro, F. Vecchione, A. D'onofrio, M. Fero', R. Calabro', S. Gustafsson, E. Ihse, M. Henein, P. Westermark, O. Suhr, P. Lindqvist, M. Oliva Sandoval, M. Gonzalez Carrillo, M. Garcia Navarro, E. Garcia-Molina Saez, M. Sabater Molina, D. Saura Espin, J. Lacunza Ruiz, J. Gimeno Blanes, G. De La Morena Valenzuela, M. Valdes Chavarri, C. Prinz, L. Faber, D. Horstkotte, H. Hoetz, J. Voigt, F. Gandara, M. Correia, I. Rosario, C. Fonseca, I. Arroja, A. Aleixo, A. Martins, L. Radulescu, D. Dan Radulescu, P. Parv Andreea, D. Duncea Caius, C. Ciuleanu T, M. Mitrea Paulina, F. Cali Quaglia, M. Ribezzo, M. Boffini, M. Rinaldi, A. M. Maceira Gonzalez, J. Cosin-Sales, E. Dalli, J. Diago, J. Aguilar, J. Ruvira, S. Goncalves, A. Gomes, F. Pinto, W.-C. Tsai, Y.-W. Liu, J.-Y. Shih, Y.-Y. Huang, J.-Y. Chen, L.-M. Tsai, J.-H. Chen, S. Ribeiro, D. Doroteia, L. Santos, C. David, G. Vinhas De Sousa, A. Almeida, M. Iwase, Y. Itou, S. Yasukochi, K. Shiino, H. Inuzuka, K. Sugimoto, Y. Ozaki, K. Gieszczyk-Strozik, A. Sikora-Puz, M. Mizia, B. Lasota, A. Chmiel, A. Lis-Swiety, J. Michna, L. Brzezinska-Wcislo, K. Mizia-Stec, Z. Gasior, P. Luijendijk, H. De Bruin-Bon, C. Zwiers, J. Vriend, R. Van Den Brink, B. Mulder, B. Bouma, S. Brigido, P. Gianfagna, A. Proclemer, B. Plicht, P. Kahlert, H. Kaelsch, T. Buck, R. Erbel, T. Konorza, H. Yoon, K. Kim, Y. Ahn, M. Jeong, J. Cho, J. Park, J. Kang, W. Rha, W. W. Jansen Klomp, G. Brandon Bravo Bruinsma, A. Van 'T Hof, S. Spanjersberg, A. Nierich, T. Bombardini, S. Gherardi, E. Picano, A. Ciarka, L. Herbots, E. Eroglu, J. Van Cleemput, W. Droogne, R. Jasityte, B. Meyns, J. D'hooge, J. Vanhaecke, M. Al Barjas, R. Iskreva, R. Morris, J. Davar, Y. Zhao, A. Holmgren, S. Morner, J. Stepanovic, B. Beleslin, M. Nedeljkovic, S. Mazic, V. Stojanov, R. Piatkowski, J. Kochanowski, P. Scislo, M. Grabowski, M. Marchel, M. Roik, D. Kosior, G. Opolski, A. Tomaszewski, A. Kutarski, M. Tomaszewski, S. Eibel, E. Hasheminejad, C. Mukherjee, H. Tschernich, J. Ender, I. Delithanasis, J. Celutkiene, C. Kenny, M. Monaghan, S. Van Den Oord, G. Ten Kate, Z. Akkus, G. Renaud, E. Sijbrands, F. Ten Cate, N. De Jong, J. Bosch, A. Van Der Steen, A. Schinkel, A. Lisowska, M. Knapp, A. Tycinska, R. Sawicki, P. Kralisz, B. Sobkowicz, S.-A. Chang, S.-C. Lee, E.-Y. Kim, S.-H. Hahm, G.-T. Ahn, M.-K. Sohn, S.-J. Park, J.-O. Choi, S.-W. Park, J.-K. Oh, M. O. Gursoy, T. Gokdeniz, M. Astarcioglu, Z. Bayram, B. Cakal, S. Karakoyun, M. Kalcik, G. Kahveci, M. Yildiz, M. Ozkan, V. Skidan, A. Borowski, M. Park, J. Thomas, S. Ranjbar, S. Hassantash, M. Karvandi, M. Foroughi, E. S. Davidsen, D. Cramariuc, O. Bleie, E. Gerdts, K. Matre, M. Cusma' Piccione, G. Bagnato, M. Mohammed, S. Piluso, L. Oreto, T. Bitter, S. Carvalho, M. Canada, M. Santisteban Sanchez De Puerta, M. D. Mesa Rubio, M. Ruiz Ortiz, M. Delgado Ortega, M. L. Pena Pena, M. Puentes Chiachio, J. Suarez De Lezo Cruz-Conde, M. Pan Alvarez-Ossorio, F. Mazuelos Bellido, J. Suarez De Lezo Herreros De Tejada, E. Altekin, A. Yanikoglu, S. Karakas, C. Oncel, B. Akdemir, A. Belgi Yildirim, A. Cilli, H. Yilmaz, L. Lenartowska, M. Furdal, B. Knysz, A. Konieczny, J. Lewczuk, S. Severino, M. Cavallaro, M. Coppola, H. Motoki, A. To, M. Bhargava, O. Wazni, T. Marwick, A. Klein, E. Sinkovskaya, S. Horton, A. Abuhamad, S. Mingo Santos, V. Monivas Palomero, B. Beltran Correas, C. Mitroi, C. Gutierrez Landaluce, I. Garcia Lunar, J. Gonzalez Mirelis, M. Cavero, J. Segovia Cubero, L. Alonso Pulpon, E. Gurel, T. Karaahmet, K. Tigen, C. Kirma, C. Dundar, S. Pala, I. Isiklar, C. Cevik, A. Kilicgedik, Y. Basaran, M. Brambatti, A. Romandini, A. Barbarossa, S. Molini, A. Urbinati, A. Giovagnoli, L. Cipolletta, A. Capucci, S. Park, E. Choi, C. Ahn, S. Hong, M. Kim, D. Lim, W. Shim, J. Xie, F. Fang, Q. Zhang, J. Chan, G. Yip, J. Sanderson, Y. Lam, B. Yan, C. Yu, P. Jorge Perez, A. De La Rosa Hernandez, C. Hernandez Garcia, A. Duque Garcia, A. Barragan Acea, E. Arroyo Ucar, J. Jimenez Rivera, J. Lacalzada Almeida, I. Laynez Cerdena, C. Carminati, R. Capoulade, E. Larose, M. Clavel, J. Dumesnil, M. Arsenault, E. Bedard, P. Mathieu, P. Pibarot, L. Gargani, G. Baldi, F. Forfori, D. Caramella, L. D'errico, A. Abramo, R. Sicari, F. Giunta, W.-N. Lee, B. Larrat, E. Messas, M. Pernot, M. Tanter, V. Velagic, M. Cikes, R. Matasic, I. Skorak, J. Samardzic, D. Puljevic, M. Lovric Bencic, B. Biocina, D. Milicic, B. Roosens, G. Bala, S. Droogmans, J. Hostens, J. Somja, E. Delvenne, J. Schiettecatte, T. Lahoutte, G. Van Camp, B. Cosyns, A. Ghosh, R. Hardy, N. Chaturvedi, J. Deanfield, D. Pellerin, D. Kuh, A. Hughes, A. Malmgren, M. Dencker, M. Stagmo, P. Gudmundsson, Y. Seo, T. Ishizu, K. Aonuma, M. J. Schuuring, J. Vis, A. Van Dijk, J. Van Melle, P. Pieper, H. Vliegen, G. Sieswerda, E. Foukarakis, A. Pitarokilis, P. Kafarakis, A. Kiritsi, E. Klironomos, A. Manousakis, X. Fragiadaki, E. Papadakis, and A. Dermitzakis
- Subjects
medicine.medical_specialty ,business.industry ,Thursday ,medicine ,Radiology, Nuclear Medicine and imaging ,Medical physics ,General Medicine ,Session (computer science) ,Cardiology and Cardiovascular Medicine ,business ,Surgery - Published
- 2011
- Full Text
- View/download PDF
4. In-vivo dark-field and phase-contrast x-ray imaging
- Author
-
Bart Pauwels, Andre Yaroshenko, Martin Bech, Alexander Sasov, Arne Tapfer, J Hostens, Peter Bruyndonckx, Franz Pfeiffer, and Astrid Velroyen
- Subjects
Diagnostic Imaging ,Lung Diseases ,Scanner ,Pathology ,medicine.medical_specialty ,media_common.quotation_subject ,Radiography ,Respiratory System ,Contrast Media ,02 engineering and technology ,Article ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Nuclear magnetic resonance ,In vivo ,Contrast (vision) ,Medicine ,Animals ,media_common ,Multidisciplinary ,business.industry ,Phase-contrast X-ray imaging ,X-Rays ,021001 nanoscience & nanotechnology ,Dark field microscopy ,3. Good health ,0210 nano-technology ,business ,Radiology, Nuclear Medicine and Medical Imaging - Abstract
Novel radiography approaches based on the wave nature of x-rays when propagating through matter have a great potential for improved future x-ray diagnostics in the clinics. Here, we present a significant milestone in this imaging method: in-vivo multi-contrast x-ray imaging of a mouse using a compact scanner. Of particular interest is the enhanced contrast in regions related to the respiratory system, indicating a possible application in diagnosis of lung diseases (e.g. emphysema).
- Published
- 2013
5. 167 Combination with PI3 kinase inhibitors allows drastic dose reduction of tumor necrosis factor
- Author
-
A. Goethals, L. Huyghe, Peter Brouckaert, J. Hostens, and M. Van den Hemel
- Subjects
Cancer Research ,Oncology ,Chemistry ,Cancer research ,Dose reduction ,Tumor necrosis factor alpha ,PI3-Kinase Inhibitors ,Vascular endothelial growth inhibitor - Published
- 2004
- Full Text
- View/download PDF
6. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.
- Author
-
Verleden SE, Tanabe N, McDonough JE, Vasilescu DM, Xu F, Wuyts WA, Piloni D, De Sadeleer L, Willems S, Mai C, Hostens J, Cooper JD, Verbeken EK, Verschakelen J, Galban CJ, Van Raemdonck DE, Colby TV, Decramer M, Verleden GM, Kaminski N, Hackett TL, Vanaudenaerde BM, and Hogg JC
- Subjects
- Bronchioles diagnostic imaging, Bronchioles pathology, Female, Humans, Idiopathic Pulmonary Fibrosis diagnostic imaging, Idiopathic Pulmonary Fibrosis surgery, Lung diagnostic imaging, Lung pathology, Lung Transplantation, Male, Middle Aged, Multidetector Computed Tomography, Multimodal Imaging, Retrospective Studies, X-Ray Microtomography, Idiopathic Pulmonary Fibrosis pathology
- Abstract
Background: The observation that patients with idiopathic pulmonary fibrosis (IPF) can have higher than normal expiratory flow rates at low lung volumes led to the conclusion that the airways are spared in IPF. This study aimed to re-examine the hypothesis that airways are spared in IPF using a multiresolution imaging protocol that combines multidetector CT (MDCT), with micro-CT and histology., Methods: This was a retrospective cohort study comparing explanted lungs from patients with severe IPF treated by lung transplantation with a cohort of unused donor (control) lungs. The donor control lungs had no known lung disease, comorbidities, or structural lung injury, and were deemed appropriate for transplantation on review of the clinical files. The diagnosis of IPF in the lungs from patients was established by a multidisciplinary consensus committee according to existing guidelines, and was confirmed by video-assisted thoracic surgical biopsy or by pathological examination of the contralateral lung. The control and IPF groups were matched for age, sex, height, and bodyweight. Samples of lung tissue were compared using the multiresolution imaging approach: a cascade of clinical MDCT, micro-CT, and histological imaging. We did two experiments: in experiment 1, all the lungs were randomly sampled; in experiment 2, samples were selected from regions of minimal and established fibrosis. The patients and donors were recruited from the Katholieke Universiteit Leuven (Leuven, Belgium) and the University of Pennsylvania Hospital (Philadelphia, PA, USA). The study took place at the Katholieke Universiteit Leuven, and the University of British Columbia (Vancouver, BC, Canada)., Findings: Between Oct 5, 2009, and July 22, 2016, explanted lungs from patients with severe IPF (n=11), were compared with a cohort of unused donor (control) lungs (n=10), providing 240 samples of lung tissue for comparison using the multiresolution imaging approach. The MDCT specimen scans show that the number of visible airways located between the ninth generation (control 69 [SD 22] versus patients with IPF 105 [33], p=0·0023) and 14th generation (control 9 [6] versus patients with IPF 49 [28], p<0·0001) of airway branching are increased in patients with IPF, which we show by micro-CT is due to thickening of their walls and distortion of their lumens. The micro-CT analysis showed that compared with healthy (control) lung anatomy (mean 5·6 terminal bronchioles per mL [SD 1·6]), minimal fibrosis in IPF tissue was associated with a 57% loss of the terminal bronchioles (mean 2·4 terminal bronchioles per mL [SD 1·0]; p<0·0001), the appearance of fibroblastic foci, and infiltration of the tissue by inflammatory immune cells capable of forming lymphoid follicles. Established fibrosis in IPF tissue had a similar reduction (66%) in the number of terminal bronchioles (mean 1·9 terminal bronchioles per mL [SD 1·4]; p<0·0001) and was dominated by increased airspace size, Ashcroft fibrosis score, and volume fractions of tissue and collagen., Interpretation: Small airways disease is a feature of IPF, with significant loss of terminal bronchioles occuring within regions of minimal fibrosis. On the basis of these findings, we postulate that the small airways could become a potential therapeutic target in IPF., Funding: Katholieke Universiteit Leuven, US National Institutes of Health, BC Lung Association, and Genentech., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
7. Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies.
- Author
-
Huyghe L, Van Parys A, Cauwels A, Van Lint S, De Munter S, Bultinck J, Zabeau L, Hostens J, Goethals A, Vanderroost N, Verhee A, Uzé G, Kley N, Peelman F, Vandekerckhove B, Brouckaert P, and Tavernier J
- Subjects
- Animals, Mice, Mice, Inbred C57BL, Mice, Transgenic, Immunotherapy, Neoplasms therapy, Tumor Necrosis Factor-alpha
- Abstract
Systemic toxicities have severely limited the clinical application of tumor necrosis factor (TNF) as an anticancer agent. Activity-on-Target cytokines (AcTakines) are a novel class of immunocytokines with improved therapeutic index. A TNF-based AcTakine targeted to CD13 enables selective activation of the tumor neovasculature without any detectable toxicity in vivo. Upregulation of adhesion markers supports enhanced T-cell infiltration leading to control or elimination of solid tumors by, respectively, CAR T cells or a combination therapy with CD8-targeted type I interferon AcTakine. Co-treatment with a CD13-targeted type II interferon AcTakine leads to very rapid destruction of the tumor neovasculature and complete regression of large, established tumors. As no tumor markers are needed, safe and efficacious elimination of a broad range of tumor types becomes feasible., (© 2020 The Authors. Published under the terms of the CC BY 4.0 license.)
- Published
- 2020
- Full Text
- View/download PDF
8. Evaluation of Root Canal Preparation Using Rotary System and Hand Instruments Assessed by Micro-Computed Tomography.
- Author
-
Stavileci M, Hoxha V, Görduysus Ö, Tatar I, Laperre K, Hostens J, Küçükkaya S, and Muhaxheri E
- Subjects
- Bicuspid pathology, Dental Pulp Cavity surgery, Humans, Dental Instruments, Dental Pulp Cavity diagnostic imaging, Root Canal Preparation instrumentation, Root Canal Preparation methods, Root Canal Preparation standards, X-Ray Microtomography methods
- Abstract
Background: Complete mechanical preparation of the root canal system is rarely achieved. Therefore, the purpose of this study was to evaluate and compare the root canal shaping efficacy of ProTaper rotary files and standard stainless steel K-files using micro-computed tomography., Material and Methods: Sixty extracted upper second premolars were selected and divided into 2 groups of 30 teeth each. Before preparation, all samples were scanned by micro-computed tomography. Thirty teeth were prepared with the ProTaper system and the other 30 with stainless steel files. After preparation, the untouched surface and root canal straightening were evaluated with micro-computed tomography. The percentage of untouched root canal surface was calculated in the coronal, middle, and apical parts of the canal. We also calculated straightening of the canal after root canal preparation. Results from the 2 groups were statistically compared using the Minitab statistical package., Results: ProTaper rotary files left less untouched root canal surface compared with manual preparation in coronal, middle, and apical sector (p<0.001). Similarly, there was a statistically significant difference in root canal straightening after preparation between the techniques (p<0.001)., Conclusions: Neither manual nor rotary techniques completely prepared the root canal, and both techniques caused slight straightening of the root canal.
- Published
- 2015
- Full Text
- View/download PDF
9. The site and nature of airway obstruction after lung transplantation.
- Author
-
Verleden SE, Vasilescu DM, Willems S, Ruttens D, Vos R, Vandermeulen E, Hostens J, McDonough JE, Verbeken EK, Verschakelen J, Van Raemdonck DE, Rondelet B, Knoop C, Decramer M, Cooper J, Hogg JC, Verleden GM, and Vanaudenaerde BM
- Subjects
- Adult, Aged, Bronchiolitis Obliterans diagnostic imaging, Bronchiolitis Obliterans etiology, Bronchography, Case-Control Studies, Female, Graft Rejection diagnostic imaging, Graft Rejection etiology, Humans, Male, Middle Aged, Pulmonary Alveoli diagnostic imaging, Bronchioles pathology, Bronchiolitis Obliterans pathology, Graft Rejection pathology, Lung Transplantation, Multidetector Computed Tomography, Pulmonary Alveoli pathology, X-Ray Microtomography
- Abstract
Rationale: The chronic rejection of lung allografts is attributable to progressive small airway obstruction., Objectives: To determine precisely the site and nature of this type of airway obstruction., Methods: Lungs from patients with rejected lung allografts treated by a second transplant (n = 7) were compared with unused donor (control) lungs (n = 7) using multidetector computed tomography (MDCT) to determine the percentage of visible airways obstructed in each airway generation, micro-computed tomography (microCT) to visualize the site of obstruction, and histology to determine the nature of this obstruction., Measurements and Main Results: The number of airways visible with MDCT was not different between rejected and control lungs. However, 10 ± 7% of observed airways greater than 2 mm in diameter, 50 ± 22% of airways between 1 and 2 mm in diameter, and 73 ± 10% of airways less than 1 mm in diameter were obstructed in the rejected lungs. MicroCT confirmed that the mean lumen diameter of obstructed airways was 647 ± 317 μm but showed no difference in either total number and cross-sectional area of the terminal bronchioles or in alveolar dimensions (mean linear intercept) between groups (P > 0.05). In addition, microCT demonstrated that only segments of the airways are obstructed. Histology confirmed a constrictive form of bronchiolitis caused by expansion of microvascular-rich granulation tissue in some locations and collagen-rich scar tissue in others., Conclusions: Chronic lung allograft rejection is associated with a progressive form of constrictive bronchiolitis that targets conducting airways while sparing larger airways as well as terminal bronchioles and the alveolar surface.
- Published
- 2014
- Full Text
- View/download PDF
10. In-vivo dark-field and phase-contrast x-ray imaging.
- Author
-
Bech M, Tapfer A, Velroyen A, Yaroshenko A, Pauwels B, Hostens J, Bruyndonckx P, Sasov A, and Pfeiffer F
- Subjects
- Animals, Contrast Media chemistry, Lung Diseases diagnosis, Mice, Radiography, Respiratory System diagnostic imaging, X-Rays, Diagnostic Imaging methods
- Abstract
Novel radiography approaches based on the wave nature of x-rays when propagating through matter have a great potential for improved future x-ray diagnostics in the clinics. Here, we present a significant milestone in this imaging method: in-vivo multi-contrast x-ray imaging of a mouse using a compact scanner. Of particular interest is the enhanced contrast in regions related to the respiratory system, indicating a possible application in diagnosis of lung diseases (e.g. emphysema).
- Published
- 2013
- Full Text
- View/download PDF
11. Echocardiographic integrated backscatter for assessing reduction of aortic valve calcifications by R-568 in a rat model of chronic kidney disease.
- Author
-
Roosens B, Bala G, Droogmans S, Hostens J, Somja J, Delvenne E, Schiettecatte J, Delvenne P, Caveliers V, Lahoutte T, Van Camp G, and Cosyns B
- Subjects
- Aniline Compounds, Animals, Aortic Valve diagnostic imaging, Bicuspid Aortic Valve Disease, Calcinosis etiology, Heart Defects, Congenital etiology, Heart Valve Diseases etiology, Image Interpretation, Computer-Assisted methods, Male, Phenethylamines, Propylamines, Rats, Rats, Wistar, Renal Insufficiency, Chronic complications, Reproducibility of Results, Scattering, Radiation, Sensitivity and Specificity, Systems Integration, Treatment Outcome, Calcinosis diagnostic imaging, Calcinosis prevention & control, Echocardiography methods, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital prevention & control, Heart Valve Diseases diagnostic imaging, Heart Valve Diseases prevention & control, Renal Insufficiency, Chronic diagnostic imaging, Renal Insufficiency, Chronic drug therapy
- Abstract
Chronic kidney disease (CKD) and secondary hyper-parathyroidism are associated with calcific aortic valve disease (CAVD). Innovative modalities for imaging CAVD are warranted. Our aim was to use echocardiographic calibrated integrated backscatter (cIB) to quantitatively determine the preventive effect of the calcimimetic R-568 on CAVD in a CKD rat model, and to compare the results with those of micro-computed tomography and histology. Thirty-six male Wistar rats were followed for 7 wk. Rats were divided into four groups with respect to treatment: (1) adenine 0.5% to induce CKD + vehicle; (2) adenine + R-568 (30 mg/kg/d); (3) control, normal diet + vehicle; (4) controls, normal diet + R-568. At week 7, cIB values of the aortic valve were significantly lower in R-568-treated group 2 than in vehicle-treated group 1. This was confirmed by the significantly lower calcified volume observed on micro-computed tomography and the calcified area observed on histology. There were no significant differences in fractional area change and aortic valve area between groups. In conclusion, echocardiographic cIB was able to quantitatively assess a reduction in CAVD by R-568 in a rat model of CKD., (Copyright © 2013 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
12. Eupolybothrus cavernicolus Komerički & Stoev sp. n. (Chilopoda: Lithobiomorpha: Lithobiidae): the first eukaryotic species description combining transcriptomic, DNA barcoding and micro-CT imaging data.
- Author
-
Stoev P, Komerički A, Akkari N, Liu S, Zhou X, Weigand AM, Hostens J, Hunter CI, Edmunds SC, Porco D, Zapparoli M, Georgiev T, Mietchen D, Roberts D, Faulwetter S, Smith V, and Penev L
- Abstract
We demonstrate how a classical taxonomic description of a new species can be enhanced by applying new generation molecular methods, and novel computing and imaging technologies. A cave-dwelling centipede, Eupolybothrus cavernicolus Komerički & Stoev sp. n. (Chilopoda: Lithobiomorpha: Lithobiidae), found in a remote karst region in Knin, Croatia, is the first eukaryotic species for which, in addition to the traditional morphological description, we provide a fully sequenced transcriptome, a DNA barcode, detailed anatomical X-ray microtomography (micro-CT) scans, and a movie of the living specimen to document important traits of its ex-situ behaviour. By employing micro-CT scanning in a new species for the first time, we create a high-resolution morphological and anatomical dataset that allows virtual reconstructions of the specimen and subsequent interactive manipulation to test the recently introduced 'cybertype' notion. In addition, the transcriptome was recorded with a total of 67,785 scaffolds, having an average length of 812 bp and N50 of 1,448 bp (see GigaDB). Subsequent annotation of 22,866 scaffolds was conducted by tracing homologs against current available databases, including Nr, SwissProt and COG. This pilot project illustrates a workflow of producing, storing, publishing and disseminating large data sets associated with a description of a new taxon. All data have been deposited in publicly accessible repositories, such as GigaScience GigaDB, NCBI, BOLD, Morphbank and Morphosource, and the respective open licenses used ensure their accessibility and re-usability.
- Published
- 2013
- Full Text
- View/download PDF
13. Four-dimensional visualization of subpleural alveolar dynamics in vivo during uninterrupted mechanical ventilation of living swine.
- Author
-
Namati E, Warger WC 2nd, Unglert CI, Eckert JE, Hostens J, Bouma BE, and Tearney GJ
- Abstract
Pulmonary alveoli have been studied for many years, yet no unifying hypothesis exists for their dynamic mechanics during respiration due to their miniature size (100-300 μm dimater in humans) and constant motion, which prevent standard imaging techniques from visualizing four-dimensional dynamics of individual alveoli in vivo. Here we report a new platform to image the first layer of air-filled subpleural alveoli through the use of a lightweight optical frequency domain imaging (OFDI) probe that can be placed upon the pleura to move with the lung over the complete range of respiratory motion. This device enables in-vivo acquisition of four-dimensional microscopic images of alveolar airspaces (alveoli and ducts), within the same field of view, during continuous ventilation without restricting the motion or modifying the structure of the alveoli. Results from an exploratory study including three live swine suggest that subpleural alveolar air spaces are best fit with a uniform expansion (r (2) = 0.98) over a recruitment model (r (2) = 0.72). Simultaneously, however, the percentage change in volume shows heterogeneous alveolar expansion within just a 1 mm x 1 mm field of view. These results signify the importance of four-dimensional imaging tools, such as the device presented here. Quantification of the dynamic response of the lung during ventilation may help create more accurate modeling techniques and move toward a more complete understanding of alveolar mechanics.
- Published
- 2013
- Full Text
- View/download PDF
14. Effects of preparation techniques on root canal shaping assessed by micro-computed tomography.
- Author
-
Stavileci M, Hoxha V, Görduysus Ö, Tatar I, Laperre K, Hostens J, Küçükkaya S, and Berisha M
- Subjects
- Analysis of Variance, Dental Instruments, Dental Pulp Cavity surgery, Humans, Stainless Steel, Dental Pulp Cavity diagnostic imaging, Root Canal Preparation methods, X-Ray Microtomography methods
- Abstract
Background: Root canal shaping without any procedural error is of the utmost preference. Therefore, the purpose of this study was to use micro-computed tomography to evaluate and compare the root canal shaping efficacy of ProTaper rotary files and standard stainless steel K-files., Material and Methods: Sixty extracted upper second premolars were selected and were divided into 2 groups of 30. Before preparation, all samples were scanned by micro-CT. Then, 30 teeth were prepared with stainless steel files and the remaining 30 with ProTaper rotary files. Canal transportation and centering ability before and after root canal shaping were assessed using micro-CT. The amount and direction of canal transportation and the centering ratio of each instrument were determined in the coronal, middle, and apical parts of the canal. The 2 groups were statistically compared using one-way ANOVA., Results: ProTaper rotary files gave less transportation (p<0.001) and better centering ability (p<0.00001) compared with stainless steel files., Conclusions: The manual technique for preparation of root canals with stainless steel files produces more canal transportation, whereas rotary files remain more centered in the canal.
- Published
- 2013
- Full Text
- View/download PDF
15. Validation of two-dimensional and three-dimensional measurements of subpleural alveolar size parameters by optical coherence tomography.
- Author
-
Unglert CI, Warger WC, Hostens J, Namati E, Birngruber R, Bouma BE, and Tearney GJ
- Subjects
- Animals, Computer Simulation, Image Enhancement methods, Models, Biological, Organ Size physiology, Pleura, Reproducibility of Results, Sensitivity and Specificity, Swine, Tomography, X-Ray Computed methods, Algorithms, Image Interpretation, Computer-Assisted methods, Imaging, Three-Dimensional methods, Pattern Recognition, Automated methods, Pulmonary Alveoli anatomy & histology, Pulmonary Alveoli physiology, Tomography, Optical Coherence methods
- Abstract
Optical coherence tomography (OCT) has been increasingly used for imaging pulmonary alveoli. Only a few studies, however, have quantified individual alveolar areas, and the validity of alveolar volumes represented within OCT images has not been shown. To validate quantitative measurements of alveoli from OCT images, we compared the cross-sectional area, perimeter, volume, and surface area of matched subpleural alveoli from microcomputed tomography (micro-CT) and OCT images of fixed air-filled swine samples. The relative change in size between different alveoli was extremely well correlated (r>0.9, P<0.0001), but OCT images underestimated absolute sizes compared to micro-CT by 27% (area), 7% (perimeter), 46% (volume), and 25% (surface area) on average. We hypothesized that the differences resulted from refraction at the tissue-air interfaces and developed a ray-tracing model that approximates the reconstructed alveolar size within OCT images. Using this model and OCT measurements of the refractive index for lung tissue (1.41 for fresh, 1.53 for fixed), we derived equations to obtain absolute size measurements of superellipse and circular alveoli with the use of predictive correction factors. These methods and results should enable the quantification of alveolar sizes from OCT images in vivo.
- Published
- 2012
- Full Text
- View/download PDF
16. The influence of exposure parameters on jawbone model accuracy using cone beam CT and multislice CT.
- Author
-
Vandenberghe B, Luchsinger S, Hostens J, Dhoore E, and Jacobs R
- Subjects
- Cadaver, Humans, Radiation Dosage, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Cone-Beam Computed Tomography methods, Jaw, Edentulous diagnostic imaging, X-Ray Microtomography methods
- Abstract
Objective: The main purpose of this study was to investigate the influence of exposure parameters on jawbone model accuracy when using cone beam CT (CBCT) and multislice CT (MSCT)., Methods: A lower and an upper edentulous human cadaver jaw were scanned using micro-CT (Skyscan 1173 high energy spiral scan micro-CT; Skyscan NV, Kontich, Belgium) at 35 μm to serve as true reference. The in vitro samples were exposed using six CBCT units and one MSCT system. CBCT exposure protocols were chosen according to clinically available settings. The variables were kilovoltage, milliamperage, voxel size and/or scan time. Image segmentation was based on local thresholds using profile lines. The resulting jawbone segmentations were registered with the reference and image processing was done to internally fill the segmentations. A point-based distance calculation was performed between the three-dimensional objects and reference scans and deviation percentages were calculated for 2 mm, 1 mm and 0.5 mm intervals., Results: All points of the MSCT surface models lay within a 1 mm deviation range and 98.5% within 0.5 mm compared with micro-CT. For the different CBCT systems, accuracy came close to MSCT with mean percentages of 98.9% within 1 mm deviation and 92.8% within 0.5 mm. A difference of approximately 1% between lower and upper jaws could be perceived. For the specific CBCT exposure protocols, only scan time and voxel size revealed certain significant differences., Conclusion: Jawbone model accuracy using CBCT was comparable with MSCT. The surface models of the upper jaws deviated slightly more than those for lower jaws. CBCT exposure settings had a limited influence on accuracy with scan time and voxel size as the main factors.
- Published
- 2012
- Full Text
- View/download PDF
17. Occurrence of cardiovascular calcifications in normal, aging rats.
- Author
-
Roosens B, Bala G, Droogmans S, Hostens J, Somja J, Delvenne E, Schiettecatte J, Delvenne P, Lahoutte T, Van Camp G, and Cosyns B
- Subjects
- Animals, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Calcinosis diagnostic imaging, Cardiomyopathies diagnostic imaging, Disease Progression, Male, Rats, Rats, Inbred Lew, Rats, Wistar, Ultrasonography, Ventricular Function, Left physiology, X-Ray Microtomography, Aging physiology, Calcinosis physiopathology, Cardiomyopathies physiopathology
- Abstract
Background: Cardiovascular calcification is an independent predictor of morbidity and mortality and increases with age. Animal models are frequently used to investigate the underlying pathophysiology. Only scarce data regarding the effect of aging on calcifications in these animal models are available. The aim of this study is to investigate the occurrence of cardiovascular calcifications in normal, aging rats., Methods: A mixed inbred/outbred population of 44 male Lewis/Wistar rats was studied. Group 1 of three-month-old rats, group 2 twelve-month-old, group 3 twenty-four-month-old and group 4 thirty-month-old rats. Calibrated integrated backscatter (cIB) values and blood parameters (creatinine, parathyroid hormone (PTH)) were measured, followed by ex-vivo micro-CT and histology as reference methods., Results: Cardiovascular calcifications developed with age, as demonstrated by significantly increasing cIB values of the aortic valve and myocardium. This was confirmed by a significant increase in the calcified volume on ex-vivo micro-CT and in the histological calcium score. There was also a significantly higher level of creatinine and PTH with age., Conclusions: As in humans, cardiovascular calcifications progressively increase with age in the normal rat. Therefore the aging rat model could be used for studying calcifying cardiovascular disease. cIB might have a value in future studies for the early detection of subclinical calcifications in humans., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
18. Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography.
- Author
-
De Langhe E, Vande Velde G, Hostens J, Himmelreich U, Nemery B, Luyten FP, Vanoirbeek J, and Lories RJ
- Subjects
- Animals, Bleomycin, Mice, Pancreatic Elastase, Algorithms, Emphysema diagnosis, Lung Volume Measurements methods, Pulmonary Fibrosis diagnosis, X-Ray Microtomography methods
- Abstract
Background: In vivo high-resolution micro-computed tomography allows for longitudinal image-based measurements in animal models of lung disease. The combination of repetitive high resolution imaging with fully automated quantitative image analysis in mouse models of lung fibrosis lung benefits preclinical research. This study aimed to develop and validate such an automated micro-computed tomography analysis algorithm for quantification of aerated lung volume in mice; an indicator of pulmonary fibrosis and emphysema severity., Methodology: Mice received an intratracheal instillation of bleomycin (n = 8), elastase (0.25 U elastase n = 9, 0.5 U elastase n = 8) or saline control (n = 6 for fibrosis, n = 5 for emphysema). A subset of mice was scanned without intervention, to evaluate potential radiation-induced toxicity (n = 4). Some bleomycin-instilled mice were treated with imatinib for proof of concept (n = 8). Mice were scanned weekly, until four weeks after induction, when they underwent pulmonary function testing, lung histology and collagen quantification. Aerated lung volumes were calculated with our automated algorithm., Principal Findings: Our automated image-based aerated lung volume quantification method is reproducible with low intra-subject variability. Bleomycin-treated mice had significantly lower scan-derived aerated lung volumes, compared to controls. Aerated lung volume correlated with the histopathological fibrosis score and total lung collagen content. Inversely, a dose-dependent increase in lung volume was observed in elastase-treated mice. Serial scanning of individual mice is feasible and visualized dynamic disease progression. No radiation-induced toxicity was observed. Three-dimensional images provided critical topographical information., Conclusions: We report on a high resolution in vivo micro-computed tomography image analysis algorithm that runs fully automated and allows quantification of aerated lung volume in mice. This method is reproducible with low inherent measurement variability. We show that it is a reliable quantitative tool to investigate experimental lung fibrosis and emphysema in mice. Its non-invasive nature has the unique benefit to allow dynamic 4D evaluation of disease processes and therapeutic interventions.
- Published
- 2012
- Full Text
- View/download PDF
19. Integrated backscatter for the in vivo quantification of supraphysiological vitamin D(3)-induced cardiovascular calcifications in rats.
- Author
-
Roosens B, Droogmans S, Hostens J, Somja J, Delvenne E, Hernot S, Bala G, Degaillier C, Caveliers V, Delvenne P, Lahoutte T, Van Camp G, and Cosyns B
- Subjects
- Animals, Aorta pathology, Aorta physiopathology, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Calcinosis chemically induced, Calcinosis physiopathology, Cardiomyopathies chemically induced, Cardiomyopathies physiopathology, Disease Models, Animal, Feasibility Studies, Heart Ventricles diagnostic imaging, Heart Ventricles physiopathology, Male, Myocardium pathology, Predictive Value of Tests, Rats, Rats, Wistar, Time Factors, Ventricular Function, Left, X-Ray Microtomography, Calcinosis diagnostic imaging, Cardiomyopathies diagnostic imaging, Cholecalciferol, Echocardiography, Doppler, Color, Image Interpretation, Computer-Assisted
- Abstract
Cardiovascular calcifications are frequently found in the aging population and are independent predictors of future cardiovascular events. Integrated backscatter (IB) of ultrasound reflectivity can easily quantify calcifications. For this purpose, 30 male Wistar rats received 25,000 IU/kg/day of vitamin D(3) (group 1, n = 8), 18,800 IU/kg/day (group 2, n = 8), or injections with the vehicle only (group 3, n = 14), for 10 weeks. Echocardiographic calibrated IB (cIB) was measured and calculated at baseline and after 10 weeks, followed by ex vivo micro-CT and histopathology of the aortic valve, ascending aorta, and myocardium. After 10 weeks, the mean cIB value of the aortic valve was significantly higher for vitamin D(3)-dosed animals compared to controls. The mean cIB value of the ascending aorta and the myocardium was also significantly higher in group 1 compared to group 3. In vivo IB results were confirmed by ex vivo micro-CT and histopathology. In conclusion, IB is a non-ionizing, feasible, and reproducible tool to quantify cardiovascular calcifications in an in vivo rat model. The integration of IB in the standard echocardiographic examination for the quantification of cardiovascular calcifications could be useful for serial evaluation of treatment efficacy and for prognosis assessment.
- Published
- 2011
- Full Text
- View/download PDF
20. Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.
- Author
-
Coppieters K, Dreier T, Silence K, de Haard H, Lauwereys M, Casteels P, Beirnaert E, Jonckheere H, Van de Wiele C, Staelens L, Hostens J, Revets H, Remaut E, Elewaut D, and Rottiers P
- Subjects
- Adalimumab, Animals, Antibodies immunology, Antibodies therapeutic use, Antibodies, Monoclonal therapeutic use, Antibodies, Monoclonal, Humanized, Camelids, New World immunology, Half-Life, Immunoglobulin Heavy Chains blood, Immunoglobulin Variable Region blood, Infliximab, Mice, Mice, Inbred BALB C, Antirheumatic Agents therapeutic use, Arthritis, Experimental therapy, Immunoglobulin Heavy Chains immunology, Immunoglobulin Heavy Chains therapeutic use, Immunoglobulin Variable Region immunology, Immunoglobulin Variable Region therapeutic use, Tumor Necrosis Factor-alpha immunology
- Abstract
Objective: The advent of tumor necrosis factor (TNF)-blocking drugs has provided rheumatologists with an effective, but highly expensive, treatment for the management of established rheumatoid arthritis (RA). Our aim was to explore preclinically the application of camelid anti-TNF VHH proteins, which are single-domain antigen binding (VHH) proteins homologous to human immunoglobulin V(H) domains, as TNF antagonists in a mouse model of RA., Methods: Llamas were immunized with human and mouse TNF, and antagonistic anti-TNF VHH proteins were isolated and cloned for bacterial production. The resulting anti-TNF VHH proteins were recombinantly linked to yield bivalent mouse and human TNF-specific molecules. To increase the serum half-life and targeting properties, an anti-serum albumin anti-TNF VHH domain was incorporated into the bivalent molecules. The TNF-neutralizing potential was analyzed in vitro. Mouse TNF-specific molecules were tested in a therapeutic protocol in murine collagen-induced arthritis (CIA). Disease progression was evaluated by clinical scoring and histologic evaluation. Targeting properties were evaluated by 99mTc labeling and gamma camera imaging., Results: The bivalent molecules were up to 500 times more potent than the monovalent molecules. The antagonistic potency of the anti-human TNF VHH proteins exceeded even that of the anti-TNF antibodies infliximab and adalimumab that are used clinically in RA. Incorporation of binding affinity for albumin into the anti-TNF VHH protein significantly prolonged its serum half-life and promoted its targeting to inflamed joints in the murine CIA model of RA. This might explain the excellent therapeutic efficacy observed in vivo., Conclusion: These data suggest that because of the flexibility of their format, camelid anti-TNF VHH proteins can be converted into potent therapeutic agents that can be produced and purified cost-effectively.
- Published
- 2006
- Full Text
- View/download PDF
21. Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics.
- Author
-
Brouckaert P, Takahashi N, van Tiel ST, Hostens J, Eggermont AM, Seynhaeve AL, Fiers W, and ten Hagen TL
- Subjects
- Animals, Antineoplastic Combined Chemotherapy Protocols pharmacokinetics, Chemotherapy, Cancer, Regional Perfusion, Doxorubicin administration & dosage, Doxorubicin pharmacokinetics, Drug Resistance, Neoplasm, Drug Screening Assays, Antitumor, Drug Synergism, Female, Melanoma, Experimental metabolism, Mice, Mice, Inbred C57BL, Tissue Distribution, Tumor Necrosis Factor-alpha administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Melanoma, Experimental drug therapy
- Abstract
The application of tumor necrosis factor-alpha (TNF) for the treatment of solid tumors is limited by its severe, life-threatening, toxicity. Therefore, only low dosages of this cytokine can be applied systemically, which results in poor tumor response. It has been demonstrated previously that administration of high-dose TNF in a so-called isolated perfusion system markedly improved tumor response when combined with chemotherapy. It appeared that TNF had a major impact specifically on the tumor-associated vasculature. At these high concentrations, endothelial cell death is induced by TNF, resulting in complete collapse of the tumor vascular bed. Strikingly, this effect alone is not enough to induce a tumor response, but addition of a chemotherapeutic drug is mandatory to obtain an anti-tumor effect. We showed that TNF has no anti-tumor effect by itself but augmented drug accumulation mainly in the tumor, most likely by enhancing vascular leakage. It seems that enhanced vascular leakage, but not endothelial cell death, explains the interaction between TNF and the co-administered drug. We hypothesized that in a low-dose setting TNF could induce tumor accumulation of chemotherapeutic drugs and consequently improve tumor response. We demonstrate that free TNF has a strong effect on the pharmacokinetics of co-administered Doxil in B16BL6 melanoma-bearing mice, resulting in strongly augmented drug accumulation in the tumor and improved tumor response. Co-injection of Stealth liposomal TNF with Doxil resulted in comparable or less pronounced tumor responses as compared to free TNF. These results imply that systemic application of clinically tolerable doses of TNF may improve drug distribution and tumor response and could be useful in a number of anti-cancer therapies., (Copyright 2004 Wiley-Liss, Inc.)
- Published
- 2004
- Full Text
- View/download PDF
22. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
- Author
-
Ameloot P, Takahashi N, Everaerdt B, Hostens J, Eugster HP, Fiers W, and Brouckaert P
- Subjects
- Animals, Antigens, CD physiology, Biological Availability, Female, Humans, Lethal Dose 50, Mice, Mice, Inbred C57BL, Receptors, Tumor Necrosis Factor physiology, Receptors, Tumor Necrosis Factor, Type I, Recombinant Proteins pharmacokinetics, Tumor Necrosis Factor-alpha administration & dosage, Tumor Necrosis Factor-alpha pharmacokinetics, Tumor Necrosis Factor-alpha toxicity
- Abstract
In mice, tumor necrosis factor (TNF) displays a selective species specificity. In contrast to murine TNF (mTNF), human TNF (hTNF) only induces lethality at extremely high doses of about 500 microg/mouse, whereas it still has a powerful antitumor activity in combination with interferon-gamma. The observation that hTNF does not interact with the p75 mTNF receptor seemed to provide a plausible explanation for these species-specific biological effects. Experiments in TNF receptor knockout mice and tests with hTNF muteins in baboons did not, however, support this hypothesis. We here show that an mTNF mutein selective for the p55 mTNF receptor induces lethality in a manner comparable to wild-type mTNF, and conclude that other differences between hTNF and mTNF must account for the reduced lethality of hTNF. Pharmacokinetics showed that hTNF is cleared much faster than mTNF or the mTNF mutein used. In contrast to the hardly lethal effect(s) of a bolus administration of hTNF, fractionated repetitive administration of the same total hTNF dose induced lethality. This suggests that prolonged exposure rather than peak levels determine the lethal effects of hTNF in mice. Experiments with receptor and ligand knockouts demonstrated that the difference in pharmacokinetics is independent of an interaction with (soluble) TNF receptor, TNF-induced effects or induction of endogenous TNF. These results show that manipulation of the clearance rate of TNF may broaden the therapeutic range of systemic treatments with TNF.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.